» Articles » PMID: 31917802

Diagnostic Performance of Serum Interferon Gamma, Matrix Metalloproteinases, and Periostin Measurements for Pulmonary Tuberculosis in Japanese Patients with Pneumonia

Overview
Journal PLoS One
Date 2020 Jan 10
PMID 31917802
Citations 6
Authors
Affiliations
Soon will be listed here.
Abstract

Serum markers that differentiate between tuberculous and non-tuberculous pneumonia would be clinically useful. However, few serum markers have been investigated for their association with either disease. In this study, serum levels of interferon gamma (IFN-γ), matrix metalloproteinases 1 and 9 (MMP-1 and MMP-9, respectively), and periostin were compared between 40 pulmonary tuberculosis (PTB) and 28 non-tuberculous pneumonia (non-PTB) patients. Diagnostic performance was assessed by analysis of receiver-operating characteristic (ROC) curves and classification trees. Serum IFN-γ and MMP-1 levels were significantly higher and serum MMP-9 levels significantly lower in PTB than in non-PTB patients (p < 0.001, p = 0.002, p < 0.001, respectively). No significant difference was observed in serum periostin levels between groups. ROC curve analysis could not determine the appropriate cut-off value with high sensitivity and specificity; therefore, a classification tree method was applied. This method identified patients with limited infiltration into three groups with statistical significance (p = 0.01), and those with MMP-1 levels < 0.01 ng/mL and periostin levels ≥ 118.8 ng/mL included only non-PTB patients (95% confidence interval 0.0-41.0). Patients with extensive infiltration were also divided into three groups with statistical significance (p < 0.001), and those with MMP-9 levels < 3.009 ng/mL included only PTB patients (95% confidence interval 76.8-100.0). In conclusion, the novel classification tree developed using MMP-1, MMP-9, and periostin data distinguished PTB from non-PTB patients. Further studies are needed to validate our cut-off values and the overall clinical usefulness of these markers.

Citing Articles

Increased serum interferon activity in sarcoidosis compared to that in tuberculosis: Implication for diagnosis?.

Schrijver B, Gopfert J, La Distia Nora R, Putera I, Nagtzaam N, Smits Te Nijenhuis M Heliyon. 2024; 10(18):e37103.

PMID: 39309852 PMC: 11416298. DOI: 10.1016/j.heliyon.2024.e37103.


Plasma immune profiling combined with machine learning contributes to diagnosis and prognosis of active pulmonary tuberculosis.

Yao F, Zhang R, Lin Q, Xu H, Li W, Ou M Emerg Microbes Infect. 2024; 13(1):2370399.

PMID: 38888093 PMC: 11225635. DOI: 10.1080/22221751.2024.2370399.


The Prognostic Value of Periostin Expression in Non-Small Cell Lung Cancer: A Meta-Analysis.

Li M, Ma G, Li X, Zhou Q Med Sci Monit. 2022; 28:e936898.

PMID: 35891604 PMC: 9341396. DOI: 10.12659/MSM.936898.


Pulmonary Functions and Inflammatory Biomarkers in Post-Pulmonary Tuberculosis Sequelae.

Shanmugasundaram K, Talwar A, Madan K, Bade G Tuberc Respir Dis (Seoul). 2022; 85(2):175-184.

PMID: 35232004 PMC: 8987661. DOI: 10.4046/trd.2021.0127.


Pathological Roles and Clinical Usefulness of Periostin in Type 2 Inflammation and Pulmonary Fibrosis.

Ono J, Takai M, Kamei A, Azuma Y, Izuhara K Biomolecules. 2021; 11(8).

PMID: 34439751 PMC: 8391913. DOI: 10.3390/biom11081084.


References
1.
Elkington P, Shiomi T, Breen R, Nuttall R, Ugarte-Gil C, Walker N . MMP-1 drives immunopathology in human tuberculosis and transgenic mice. J Clin Invest. 2011; 121(5):1827-33. PMC: 3083790. DOI: 10.1172/JCI45666. View

2.
Tamayose M, Fujita J, Parrott G, Miyagi K, Maeshiro T, Hirata T . Correlations between extent of X-ray infiltration and levels of serum C-reactive protein in adult non-severe community-acquired pneumonia. J Infect Chemother. 2015; 21(6):456-63. DOI: 10.1016/j.jiac.2015.02.009. View

3.
Peto L, Nadjm B, Horby P, Ngan T, van Doorn R, Van Kinh N . The bacterial aetiology of adult community-acquired pneumonia in Asia: a systematic review. Trans R Soc Trop Med Hyg. 2014; 108(6):326-37. PMC: 4023908. DOI: 10.1093/trstmh/tru058. View

4.
Flynn J, Chan J, Triebold K, Dalton D, Stewart T, Bloom B . An essential role for interferon gamma in resistance to Mycobacterium tuberculosis infection. J Exp Med. 1993; 178(6):2249-54. PMC: 2191274. DOI: 10.1084/jem.178.6.2249. View

5.
Koguchi Y, Kawakami K, Uezu K, Fukushima K, Kon S, Maeda M . High plasma osteopontin level and its relationship with interleukin-12-mediated type 1 T helper cell response in tuberculosis. Am J Respir Crit Care Med. 2003; 167(10):1355-9. DOI: 10.1164/rccm.200209-1113OC. View